CARESSENCETM is a solution to identify, educate and activate target patients, and their treating providers, with chronic conditions. Close diagnosis and treatment care gaps, raise awareness of chronic diseases and promote improved condition-specific diagnosis, treatment optimization and adherence. Leverage real-world data and the trusted voices of their healthcare providers to initiate meaningful health encounters between patients and their physicians/clinical care teams.
Personalized communications are delivered to patients in the trusted voice of their healthcare provider at critical points in their healthcare journey. Through omnichannel communication (email, SMS or direct mail messaging), CARESSENCE prompts patients to see their doctor, whether it’s seeking a diagnosis, optimizing treatment or supporting improved medication adherence. CARESSENCE can also conduct outreach to the target patient’s treating provider/clinical care team via SMS, direct mail or directly in the EHR to facilitate meaningful encounters where both patient and provider are ready to discuss the health issue at hand.
18 + YEARS OLD
1 6 + YEARS OLD
1 8 + YEARS OLD
1 8 + YEARS OLD
1 8 + YEARS OLD
1 8 + YEARS OLD
1 8 + YEARS OLD
1 6 + YEARS OLD
1 8 + YEARS OLD
1 8 + YEARS OLD
1 8 + YEARS OLD
40 + YEARS OLD
Leverage the power of real-world data to identify, educate and activate patients and their care teams.
When starting gets easy, share is no longer won at the counter. It is kept on the Tuesdays, one refill at a time, inside the system that can tell you whether the patient came back.
Why pharma brands need to measure movement in the patient journey, not just media response
A roadmap for how life science organizations can initiate and support more productive relationships between disparate stakeholders to enhance patient care and health
One in five people with Type 2 diabetes is living with dangerously high blood sugar levels. Without timely intervention, millions face a fast track to life-altering complications.
Within the Essence Patient Solutions network alone, 2.24 million people are living with Chronic Heart Failure. That’s 2.24 million lives teetering on the edge, millions who could face avoidable decline or death without the right intervention.
Despite clear guidelines and proven therapies, osteoporosis remains one of the most undertreated chronic conditions among women over 50. It’s also one of the most actionable opportunities for pharmaceutical brands.